Back

The relationship between sarcopenia and respiratory muscle weakness undergoing phase 2 cardiac rehabilitation in elder patients

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Sport exercise rehabilitation (6) Exercise Programmes ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Yosuke Yoshida

Nara Prefectural Seiwa Medical Center, Nara (Japan)

6 More presentations in this session

Presentation thumbnail
Blood pressure reduction through stair-walking, rationale and design of the HYPERWALK trial
Doctor E. Zavalis (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Dynamics of development of athlete's heart: continuous and high-intensity interval training in experimental models
Doctor A. Olah (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Investigating correlations in sport adaptation using artificial intelligence
Associate Professor O. Kiss (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Data driven physical activity quantification using chest strap-based heart rate measurements: the Antwerp Activity Index
Mr C. Buyck (Edegem, BE)
Abstract Slides Video
Presentation thumbnail
Do patients with cardiovascular diseases undergoing telemonitored, indirect supervised exercise training sessions achieve a personalized training heart rate range and improvement in physical capacity?
Professor E. Piotrowicz (Warsaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Sport exercise rehabilitation (6)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
The association between sarcopenia and post-discharge outcomes in patients with heart failure: data from the SMILE HF registry
thumbnail
Congress Presentation
Prevalence of sarcopenia among older adults with cardiovascular disease
thumbnail
Congress Presentation
Effectiveness of a cardiac rehabilitation program in patients with heart failure and skeletal muscle weakness

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources